Ibuprofen Found to Reduce Risk of Parkinson's Disease
|
By HospiMedica International staff writers Posted on 01 Mar 2010 |
|
People who regularly take ibuprofen, but not other nonsteroid anti-inflammatory drugs (NSAIDs) may reduce their risk of developing Parkinson's disease, according to a new study.
Researchers from the Harvard School of Public Health (HSPH; Boston, MA, USA) conducted a study that involved 136,474 people who did not have Parkinson's disease at the beginning of the research. Participants were asked about their use of NSAIDs, including aspirin, ibuprofen, and acetaminophen. Six years later, 293 of the participants had developed Parkinson's disease. The researchers found that regular users of ibuprofen (at three tablets a day) were 40% less likely to develop Parkinson's disease than people who did not take ibuprofen did. Additionally, people who took higher amounts of ibuprofen were less likely to develop Parkinson's disease than people who took smaller amounts of the drug. The outcomes were the same regardless of age, smoking, and caffeine intake. The results of the study are to be presented at the American Academy of Neurology's 62nd annual meeting, to be held during April 2010 in Toronto (ON, Canada).
"Ibuprofen was the only NSAID linked to a lower risk of Parkinson's; other NSAIDs and analgesics, including aspirin and acetaminophen, did not appear to have any effect on lowering a person's risk of developing Parkinson's,” said lead author Xiang Gao, M.D., Ph.D., of the department of nutrition at HSPH. "More research is needed as to how and why ibuprofen appears to reduce the risk of Parkinson's disease, which affects up to one million people in the United States.”
Parkinson's disease is a degenerative disorder of the central nervous system (CNS) that often impairs the sufferer's motor skills, speech, and other functions, and is both chronic and progressive. The disease is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia), and a loss of physical movement (akinesia) in extreme cases; secondary symptoms may include high-level cognitive dysfunction and subtle language problems. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine. The drug levodopa is considered the current standard treatment for Parkinson's disease.
Related Links:
Harvard School of Public Health
Researchers from the Harvard School of Public Health (HSPH; Boston, MA, USA) conducted a study that involved 136,474 people who did not have Parkinson's disease at the beginning of the research. Participants were asked about their use of NSAIDs, including aspirin, ibuprofen, and acetaminophen. Six years later, 293 of the participants had developed Parkinson's disease. The researchers found that regular users of ibuprofen (at three tablets a day) were 40% less likely to develop Parkinson's disease than people who did not take ibuprofen did. Additionally, people who took higher amounts of ibuprofen were less likely to develop Parkinson's disease than people who took smaller amounts of the drug. The outcomes were the same regardless of age, smoking, and caffeine intake. The results of the study are to be presented at the American Academy of Neurology's 62nd annual meeting, to be held during April 2010 in Toronto (ON, Canada).
"Ibuprofen was the only NSAID linked to a lower risk of Parkinson's; other NSAIDs and analgesics, including aspirin and acetaminophen, did not appear to have any effect on lowering a person's risk of developing Parkinson's,” said lead author Xiang Gao, M.D., Ph.D., of the department of nutrition at HSPH. "More research is needed as to how and why ibuprofen appears to reduce the risk of Parkinson's disease, which affects up to one million people in the United States.”
Parkinson's disease is a degenerative disorder of the central nervous system (CNS) that often impairs the sufferer's motor skills, speech, and other functions, and is both chronic and progressive. The disease is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia), and a loss of physical movement (akinesia) in extreme cases; secondary symptoms may include high-level cognitive dysfunction and subtle language problems. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine. The drug levodopa is considered the current standard treatment for Parkinson's disease.
Related Links:
Harvard School of Public Health
Gold Member
12-Channel ECG
CM1200B
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
X-Ray Generator
Advantage Plus Generators
Pediatric Mask
Respire SOFT
Latest Critical Care News
- Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
- Bedside CSF Monitor Detects Early Infection in Fluid Drains
- Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
- New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
- AI ECG Tool Detects Cardiac Amyloidosis for Early Screening
- Cuffless Wearable Enables Continuous Blood Pressure Monitoring for Hypertension Care
- AI-Guided System Supports Cardiac Ultrasound Training on Cart-Based Systems
- AI ECG Index Tracks Pubertal Maturation in Children and Adolescents
- Noninvasive AI Tool Enables Pressure-Guided Heart Failure Management
- Regenerative Therapies Aim to Support Recovery After Traumatic Brain Injury
- Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines
- “Intelligent Tattoo” Method Detects Early Melanoma Signals
- Implantable Wireless Light Device Advances Bladder Cancer Treatment
- Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read more
Surgical Techniques
view channel
CE-Marked Ultrasonic Shears Streamline Breast and Thyroid Surgery
Thyroid and breast surgeries are often performed in confined anatomical spaces near critical structures, making precise dissection and controlled thermal management essential. As the global disease burden... Read more
3D Map of Heart Electrical Wiring Aims to Guide Congenital Heart Repair
Tetralogy of Fallot is one of the most common congenital heart problems and often requires surgery in infancy. Many survivors later develop conduction abnormalities because the cardiac electrical system... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
Point of Care
view channel
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read more
Business
view channel
Endologix Adds FDA-Cleared Peripheral Thrombectomy System
Endologix (Santa Rosa, CA, USA) has acquired the Pounce Thrombectomy System from Surmodics, with the transaction closing on May 18, 2026. The FDA-cleared system is indicated for the non-surgical removal... Read more
